These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 4381864)

  • 41. Stereotype hyperactive behaviour produced by dopamine in the absence of noradrenaline.
    Scheel-Krüger J; Randrup A
    Life Sci; 1967 Jul; 6(13):1389-98. PubMed ID: 6035768
    [No Abstract]   [Full Text] [Related]  

  • 42. The effect of pargyline and desmethylimipramine on monoamine concentrations and amphetamine-induced glycogenolysis in the mouse brain.
    Hutchins DA
    Br J Pharmacol; 1979 Mar; 65(3):489-94. PubMed ID: 427324
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interaction between desipramine, tyramine, and amphetamine at adrenergic neurones.
    Brodie BB; Costa E; Groppetti A; Matsumoto C
    Br J Pharmacol; 1968 Nov; 34(3):648-58. PubMed ID: 5726793
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tyramine and monoamine oxidase inhibitors as modulators of the mitochondrial membrane permeability transition.
    Marcocci L; De Marchi U; Salvi M; Milella ZG; Nocera S; Agostinelli E; Mondovi B; Toninello A
    J Membr Biol; 2002 Jul; 188(1):23-31. PubMed ID: 12172644
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The uptake and storage of H3-norepinephrine in the reserpine-pretreated rat heart.
    Iversen LL; Glowinski J; Axelrod J
    J Pharmacol Exp Ther; 1965 Nov; 150(2):173-83. PubMed ID: 4379176
    [No Abstract]   [Full Text] [Related]  

  • 46. The effects of pargyline on overflow of transmitter and uptake of noradrenaline in the cat spleen.
    Blakeley AG; Powis G; Summers RJ
    Br J Pharmacol; 1973 Apr; 47(4):719-28. PubMed ID: 4353241
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A kinetic study of the release of noradrenaline by tyramine.
    Brandão F; Rodrigues-Pereira E; Monteiro JG; Davidson R
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Dec; 318(2):83-7. PubMed ID: 7329456
    [No Abstract]   [Full Text] [Related]  

  • 48. Effect of fluphenazine on tissue noradrenaline concentrations and its interaction with pargyline.
    Azhary RA; Khayyal MT; Saleh S
    Br J Pharmacol; 1975 Apr; 53(4):593-5. PubMed ID: 1148501
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Contractile response of rat aorta to norepinephrine and tyramine.
    Krishnamurty VS; Grollman A
    J Pharmacol Exp Ther; 1972 Aug; 182(2):264-72. PubMed ID: 5048363
    [No Abstract]   [Full Text] [Related]  

  • 50. [The comparative influence of pyrazidol, inkazan and other antidepressant monoamine oxidase inhibitors on the pressor effect of tyramine].
    Andreeva NI; Golovina SM; Faermark MF; Shvarts GIa; Mashkovskiĭ MD
    Farmakol Toksikol; 1991; 54(2):38-40. PubMed ID: 1884793
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Trace amines inhibit the electrically evoked release of [3H]acetylcholine from slices of rat striatum in the presence of pargyline: similarities between beta-phenylethylamine and amphetamine.
    Baud P; Arbilla S; Cantrill RC; Scatton B; Langer SZ
    J Pharmacol Exp Ther; 1985 Oct; 235(1):220-9. PubMed ID: 3930699
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The effect of digitoxin on myocardial noradrenaline concentration].
    Göthert M
    Arzneimittelforschung; 1971 Sep; 21(9):1333-4. PubMed ID: 5171787
    [No Abstract]   [Full Text] [Related]  

  • 53. Cation dependence of the noradrenaline-releasing action of tyramine.
    Thoenen H; Huerlimann A; Haefely W
    Eur J Pharmacol; 1969 Apr; 6(1):29-37. PubMed ID: 5784645
    [No Abstract]   [Full Text] [Related]  

  • 54. Guanethidine and related agents. I. Mechanism of the selective blockade of adrenergic neurons and its antagonism by drugs.
    Mitchell JR; Oates JA
    J Pharmacol Exp Ther; 1970 Mar; 172(1):100-7. PubMed ID: 5416937
    [No Abstract]   [Full Text] [Related]  

  • 55. Monoamine oxidase in rat arteries: evidence for different forms and selective localization.
    Coquil JF; Goridis C; Mack G; Neff NH
    Br J Pharmacol; 1973 Aug; 48(4):590-9. PubMed ID: 4788203
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of drugs on turnover rate of heart norepinephrine.
    Volicer L; Reid WD
    Int J Neuropharmacol; 1969 Jan; 8(1):1-7. PubMed ID: 5782993
    [No Abstract]   [Full Text] [Related]  

  • 57. The action of desipramine on noradrenaline depletion by reserpine in the vas deferens of the rat in vivo.
    Jane F; Planas ME; Bonaccorsi A
    J Pharm Pharmacol; 1970 May; 22(5):381-3. PubMed ID: 4393001
    [No Abstract]   [Full Text] [Related]  

  • 58. A note on the subcellular distribution of adipose tissue noradrenaline.
    Gesa GL; Congiu S; Spano PF; Musinu C
    J Pharm Pharmacol; 1968 Feb; 20(2):132-4. PubMed ID: 4384536
    [No Abstract]   [Full Text] [Related]  

  • 59. Pharmacological evidence for the existence of a neuronal amine uptake mechanism in the dog liver in vivo.
    Garceau D; Yamaguchi N
    Can J Physiol Pharmacol; 1982 Jun; 60(6):755-62. PubMed ID: 7116222
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Influence of drugs with affinity for alpha-adrenoceptors on noradrenaline release by potassium, tyramine and dimethylphenylpiperazinium.
    Starke K; Montel H
    Eur J Pharmacol; 1974 Aug; 27(3):273-80. PubMed ID: 4425057
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.